Logotype for Rainbow Children's Medicare Limited

Rainbow Children's Medicare (RAINBOW) Q1 26/27 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Rainbow Children's Medicare Limited

Q1 26/27 earnings summary

31 Jul, 2026

Executive summary

  • Achieved 33% year-on-year revenue growth in Q1 FY27, reaching INR 4,700 million, with PAT up 16% to INR 625 million and EBITDA up 30% to INR 1,346 million, driven by strong demand across core specialties and balanced contributions from mature and new hospitals.

  • Operational expansion continued with 24 hospitals across 9 cities, 2,565 beds, and over 1,075 doctors, including new agreements in Mumbai, Nellore, and Guntur, marking entry into Western India and strengthening Andhra Pradesh presence.

  • Recognized for clinical excellence with multiple JCI and NABH accreditations, awards for leadership and workplace practices, and notable achievements in complex pediatric cases.

  • Five-year plan to add 2,500 beds, targeting a total network capacity of 5,000 beds with INR 2,200 crore CapEx.

  • Unaudited standalone and consolidated financial results for Q1 FY27 were approved by the Board of Directors on July 30, 2026.

Financial highlights

  • Q1 FY27 operating revenue reached INR 4,699.9 million, up 33% year-on-year, with EBITDA at INR 1,346.5 million and a margin of 28.6%.

  • Profit after tax was INR 625.4 million, a 16% year-on-year increase.

  • Inpatient discharges, outpatient consultations, and deliveries grew by 28%, 25%, and 23% respectively.

  • Total expenses rose 32% year-on-year, mainly due to higher employee benefits and professional fees.

  • Organic revenue growth (excluding acquisitions) was 24% year-on-year.

Outlook and guidance

  • Expansion plans target 3,725 beds by FY29, with new hospitals in Coimbatore, Gurugram, Indore, Mumbai, and Pune, and completion of the Malad, Mumbai hospital expected by Q2 FY27.

  • Targeting to double top-line revenue over the next four years, implying a 20% CAGR.

  • EBITDA margin guidance for FY27 and FY28 is 24%-25% pre-Ind AS, despite recent margin pressures from rapid bed additions.

  • Acquisition of a 64% stake in Super Prime Medical Care LLP (Nellore, Andhra Pradesh) is expected to close in Q2 FY27.

  • Focus on replicating the hub-and-spoke model in new regions and tier-2 cities.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Rainbow Children's Medicare